2021 Rita Allen Scholar Nichole Scheff and colleagues found that a type of drug called peripherally restricted OPRM1 antagonists (PAMORAs) blocked opioid-induced immunosuppression and improved response rates to immune checkpoint inhibitor therapy in a mouse model of head and neck cancer.